Coya Therapeutics, Inc. Common Stock (COYA) Stock Price

COYAStock

$5.04−27.70%52W

Market Cap$118.23M

P/E—

PEG Ratio—

Div yield—

Beta0.62

COYA Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-8.98%

Price vs S&P 500 (4W)20.95%

VGM Score53.57

Book Value / Share (Quarterly)$2.09

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-0.69

Price vs S&P 500 (YTD)-26.44%

Net Profit Margin (TTM)-266.11%

EPS (TTM)$-1.15

10-Day Avg Trading Volume0.10M

EPS Excl Extra (TTM)$-1.15

EPS (Annual)$-1.27

ROI (Annual)-49.33%

Cash / Share (Quarterly)$2.16

Revenue Growth QoQ (YoY)-2.61%

ROA (Last FY)-42.49%

Revenue Growth TTM (YoY)115.44%

EBITD / Share (TTM)$-1.24

ROE (5Y Avg)-50.50%

Operating Margin (TTM)-283.64%

Cash Flow / Share (Annual)$-0.57

P/B Ratio2.24x

P/B Ratio (Quarterly)1.89x

Net Income / Employee (Annual)$-2,653,300

EV / Revenue (TTM)7.41x

Net Interest Coverage (TTM)-17.25x

ROA (TTM)-50.09%

EPS Incl Extra (Annual)$-1.27

Current Ratio (Annual)8.50x

Quick Ratio (Quarterly)14.30x

3-Month Avg Trading Volume0.18M

52-Week Price Return-27.70%

Revenue / Employee (TTM)$992,400

Tangible BV / Share (Quarterly)$1.01

P/S Ratio (Annual)13.79x

Asset Turnover (Annual)0.16x

52-Week High$7.75

EPS Excl Extra (Annual)$-1.27

26-Week Price Return2.27%

Quick Ratio (Annual)7.97x

13-Week Price Return2.48%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)15.02x

Enterprise Value$58.82M

Asset Turnover (TTM)0.19x

Revenue / Employee (Annual)$993,200

Pretax Margin (Annual)-267.10%

Cash / Share (Annual)$2.24

3-Month Return Std Dev60.18%

Net Income / Employee (TTM)$-2,640,800

ROE (Last FY)-49.33%

EPS Basic Excl Extra (Annual)$-1.27

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-1.15

ROI (TTM)-57.26%

P/S Ratio (TTM)13.80x

Revenue / Share (Annual)$0.47

Tangible BV / Share (Annual)$-0.84

Price vs S&P 500 (52W)-46.01%

Year-to-Date Return-14.48%

5-Day Price Return0.81%

EPS Normalized (Annual)$-1.27

ROA (5Y Avg)-68.64%

Net Profit Margin (Annual)-267.14%

Month-to-Date Return18.38%

Cash Flow / Share (TTM)$-1.22

EBITD / Share (Annual)$-1.35

Operating Margin (Annual)-283.87%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-50.50%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-1.15

P/TBV (Quarterly)5.01x

P/B Ratio (Annual)2.82x

Pretax Margin (TTM)-266.07%

Book Value / Share (Annual)$2.06

Price vs S&P 500 (13W)-0.31%

Beta0.62x

Revenue / Share (TTM)$0.35

ROE (TTM)-57.26%

52-Week Low$3.71

vGradeC

gGradeB

mGradeC

vgmGradeC

COYA Earnings Surprise History

Q2 25-0.36est. -0.43

Q3 25-0.13est. -0.23

Q4 25-0.34est. -0.30

Q1 26-0.32est. -0.39

Q2 26-0.28est. -0.36

COYA Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.15

4.17

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
COYACoya Therapeutics, Inc. Common Stock	C	B	C	$5.04
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80

About Coya Therapeutics, Inc. Common Stock

Coya Therapeutics is a clinical-stage biotech company developing regulatory T cell therapies for neurodegenerative, autoimmune, and metabolic diseases. The company's proprietary multi-modality platform modulates Treg function to address multiple disease indications.